Capricor Therapeutics (CAPR) announced long-term data from its ongoing HOPE-2 open label extension clinical trial, demonstrating the potential of the Company’s lead asset, deramiocel, to slow disease ...

Further information on the abstracts that Roche will present at MDA 2025 can be found below.

We are pleased to be sharing several new analyses relating to aficamten at the upcoming ACC Scientific Session & Expo,” said Stephen Heitner, M.D., Vice President, Head of Clinical Research. “The ...

Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors ...

Interested contributors have until 2 May 2025 to submit abstracts for scientific posters for the IAEA’s International Conference on Radiation Protection in Medicine — X Ray Vision .

Researchers are organizing protests and making their voices heard as Trump officials slash funding and lay off federal scientists.

International agencies are intensifying the search for Sudiksha Konanki, 20, one week after she went missing from a beach in ...

Avidity Biosciences (RNA) announced positive del-zota topline data from the Phase 1/2 EXPLORE44 trial in people living with Duchenne muscular ...

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025.Fourth positive DSMB ...

A total of 113 students have gone through the Cultural and Academic Research Experience (CARE) at Northern Arizona University ...

SAN FRANCISCO -- Most patients with HIV who received two broadly neutralizing antibodies (bNAbs) after pausing antiretroviral ...

Preservation of Skeletal Muscle Function Shown Over 3 Years Resulting in 52% Slowing of Disease-- --Data Presented at the ...